Horizon / Plein textes La base de ressources documentaires de l'IRD

IRD

 

Publications des scientifiques de l'IRD

Makiala-Mandanda S., Le Gal F., Ngwaka-Matsung N., Ahuka-Mundeke S., Onanga R., Bivigou-Mboumba B., Pukuta-Simbu E., Gerber A., Abbate J. L., Mwamba D., Berthet N., Leroy Eric, Muyembe-Tamfum J. J., Becquart Pierre. (2017). High prevalence and diversity of hepatitis viruses in suspected cases of yellow fever in the Democratic Republic of Congo. Journal of Clinical Microbiology, 55 (5), 1299-1312. ISSN 0095-1137

Accès réservé (Intranet IRD) Demander le PDF

Lien direct chez l'éditeur doi:10.1128/jcm.01847-16

Titre
High prevalence and diversity of hepatitis viruses in suspected cases of yellow fever in the Democratic Republic of Congo
Année de publication2017
Type de documentArticle référencé dans le Web of Science WOS:000400014400010
AuteursMakiala-Mandanda S., Le Gal F., Ngwaka-Matsung N., Ahuka-Mundeke S., Onanga R., Bivigou-Mboumba B., Pukuta-Simbu E., Gerber A., Abbate J. L., Mwamba D., Berthet N., Leroy Eric, Muyembe-Tamfum J. J., Becquart Pierre.
SourceJournal of Clinical Microbiology, 2017, 55 (5), p. 1299-1312. ISSN 0095-1137
RésuméThe majority of patients with acute febrile jaundice (>95%) identified through a yellow fever surveillance program in the Democratic Republic of Congo (DRC) test negative for antibodies against yellow fever virus. However, no etiological investigation has ever been carried out on these patients. Here, we tested for hepatitis A (HAV), hepatitis B (HBV), hepatitis C (HCV), hepatitis D (HDV), and hepatitis E (HEV) viruses, all of which can cause acute febrile jaundice, in patients included in the yellow fever surveillance program in the DRC. On a total of 498 serum samples collected from suspected cases of yellow fever from January 2003 to January 2012, enzyme-linked immunosorbent assay (ELISA) techniques were used to screen for antibodies against HAV (IgM) and HEV (IgM) and for antigens and antibodies against HBV (HBsAg and anti-hepatitis B core protein [HBc] IgM, respectively), HCV, and HDV. Viral loads and genotypes were determined for HBV and HVD. Viral hepatitis serological markers were diagnosed in 218 (43.7%) patients. The seroprevalences were 16.7% for HAV, 24.6% for HBV, 2.3% for HCV, and 10.4% for HEV, and 26.1% of HBV-positive patients were also infected with HDV. Median viral loads were 4.19 x 10(5) IU/ml for HBV (range, 769 to 9.82 x 10(9) IU/ml) and 1.4 x 10(6) IU/ml for HDV (range, 3.1 x 10(2) to 2.9 x 10(8) IU/ml). Genotypes A, E, and D of HBV and genotype 1 of HDV were detected. These high hepatitis prevalence rates highlight the necessity to include screening for hepatitis viruses in the yellow fever surveillance program in the DRC.
Plan de classementEntomologie médicale / Parasitologie / Virologie [052]
Descr. géo.REPUBLIQUE DEMOCRATIQUE DU CONGO
LocalisationFonds IRD [F B010069985]
Identifiant IRDfdi:010069985
Lien permanenthttp://www.documentation.ird.fr/hor/fdi:010069985

Export des données

Disponibilité des documents

Télechargment fichier PDF téléchargeable

Lien sur le Web lien chez l'éditeur

Accès réservé en accès réservé

HAL en libre accès sur HAL


Accès aux documents originaux :

Le FDI est labellisé CollEx

Accès direct

Bureau du chercheur

Site de la documentation

Espace intranet IST (accès réservé)

Suivi des publications IRD (accès réservé)

Mentions légales

Services Horizon

Poser une question

Consulter l'aide en ligne

Déposer une publication (accès réservé)

S'abonner au flux RSS

Voir les tableaux chronologiques et thématiques

Centres de documentation

Bondy

Montpellier (centre IRD)

Montpellier (MSE)

Cayenne

Nouméa

Papeete

Abidjan

Dakar

Niamey

Ouagadougou

Tunis

La Paz

Quito